News & Infos
%20(1)-1024x576.jpg&w=2048&q=75)
MedNet EC-REP at MedTec Japan 2025 – Meet Us at Booth 3303
We are pleased to announce our participation as an exhibitor at MedTec Japan 2025, one of Asia’s leading trade shows for medical device design and manufacturing. The event will take place in Tokyo from April 9–11, 2025.

Swissmedic Highlights Post-Market Surveillance Obligations for Legacy Devices
Swissmedic has released findings from a recent focused action, underscoring the critical importance of robust Post-Market Surveillance (PMS) for all medical devices.

EU Publishes Second Revision of MDCG 2023-3: Key Updates for Manufacturers
The European Commission has released the second revision of the MDCG 2023-3 guidance document in January 2025. This update includes important clarifications in line with Regulation (EU) 2024/1860

EU Commission Updates Guidance on SARS-CoV-2 Test Classification
The In Vitro Diagnostic (IVD) expert panel of the European Commission has released new scientific advice regarding SARS-CoV-2.

EU Initiative on Medical Devices and In-Vitro Diagnostics: A Targeted Evaluation
The European Commission has launched a public consultation as part of its targeted evaluation of the EU rules on medical devices and in-vitro diagnostics.

Meet Us at Arab Health 2025!
We are thrilled to announce that we will be attending Arab Health 2025, taking place from Monday, January 27, 2025, to Thursday, January 30, 2025, in Dubai.

MedNet EC-REP GmbH to Exhibit at MEDICA 2024 in Düsseldorf
We are excited to announce its participation at MEDICA 2024, the world’s leading trade fair for the medical industry, taking place from November 11th to 14th in Düsseldorf, Germany.
-1024x576.jpg&w=2048&q=75)
MedNet EC-REP GmbH Successfully Renews ISO 13485:2016 Certification
We are pleased to announce that MedNet EC-REP GmbH has successfully renewed its ISO 13485:2016 certification.
-1024x576.jpg&w=2048&q=75)
Key Changes in MDCG 2022-4 Rev 2 for Medical Device Manufacturers
The European Commission has issued the revised MDCG 2022-4 guidance, focusing on appropriate surveillance during the transition from the MDR

Deadline Alert: Submission Requirements for MDR Conformity Assessment
Important updates regarding the extended transition period for certain medical devices under Regulation (EU) 2023/607.